Heme oxygenase-1
(HO-1) is a vital enzyme in humans that primarily
regulates free heme concentrations. The overexpression of HO-1 is
commonly associated with cardiovascular and neurodegenerative diseases
including atherosclerosis and ischemic stroke. Currently, there are
no known chemical probes to detect HO-1 activity, limiting its potential
as an early diagnostic/prognostic marker in these serious diseases.
Reported here are the design, synthesis, and photophysical and biological
characterization of a coumarin–porphyrin FRET break-apart probe
to detect HO-1 activity,
Fe–L
1
. We designed
Fe–L
1
to “break-apart” upon HO-1-catalyzed porphyrin degradation,
perturbing the efficient FRET mechanism from a coumarin donor to a
porphyrin acceptor fluorophore. Analysis of HO-1 activity using
Escherichia coli
lysates overexpressing hHO-1 found that
a
6-fold
increase in emission intensity at 383 nm
was observed following incubation with NADPH. The identities of the
degradation products following catabolism were confirmed by MALDI-MS
and LC–MS, showing that porphyrin catabolism was regioselective
at the α-position. Finally, through the analysis of
Fe–L
2
, we have shown that close structural analogues
of heme are required to maintain HO-1 activity. It is anticipated
that this work will act as a foundation to design and develop new
probes for HO-1 activity in the future, moving toward applications
of live fluorescent imaging.